Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer

Bone Marrow Transplantation

Volumn 51, Issue 2, 2016, Pages 300-302

  Nelson, A A ^a   Harrington, A M ^a   Kroft, S ^a   Dahar, M A ^b   Hamadani, M ^a   Dhakal, B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b St Francis Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD20 ANTIGEN; CD45 ANTIGEN; FLUDARABINE; IMMUNOGLOBULIN G; METHOTREXATE; TACROLIMUS; TRANSCRIPTION FACTOR PAX5;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BIOPSY TECHNIQUE; CASE REPORT; CD8+ T LYMPHOCYTE; DRUG TREATMENT FAILURE; EPSTEIN BARR VIRUS INFECTION; EVENING DOSAGE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MANTLE CELL LYMPHOMA; MIDDLE AGED; MORNING DOSAGE; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; OTALGIA; POSITRON EMISSION TOMOGRAPHY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; AUTOGRAFT; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LYMPHOMA, MANTLE-CELL; PATHOLOGY; SKIN ULCER;

AUTOGRAFTS; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; SKIN ULCER;

EID: 84956921726     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.245     Document Type: Letter

References (10)

1. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer-A study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 2010; 34: 405-417
2. The International Agency for Research on Cancer. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization: Lyon, France, 2008
3. Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, Sobocinski KA et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992-5001
4. Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003; 21: 1352-1358
5. Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216
6. Cho YU, Chi HS, Jang S, Park SH, Park CJ. Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders. Am J Clin Pathol 2014; 141: 268-274
7. Elad S, Meyerowitz C, Shapira MY, Glick M, Bitan M, Amir G. Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 59-64
8. Hart M, Thakral B, Yohe S, Balfour HH Jr, Singh C, Spears M et al. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol 2014; 38: 1522-1529
9. Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 2011; 117: 4726-4735
10. Moran NR, Webster B, Lee KM, Trotman J, Kwan YL, Napoli J et al. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease. World J Gastroenterol 2015; 21: 6072-6076